Vaccines, reverse vaccinology, and bacterial pathogenesis.
about
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial VirusAnaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics ApproachThe Capricious Nature of Bacterial Pathogens: Phasevarions and Vaccine DevelopmentProteomics of Neisseria gonorrhoeae: the treasure hunt for countermeasures against an old diseaseDiscovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology.Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.A critical question for HIV vaccine development: which antibodies to induce?Recombinant proteins from Gallibacterium anatis induces partial protection against heterologous challenge in egg-laying hensProteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates.Reverse Vaccinology: An Approach for Identifying Leptospiral Vaccine Candidates.Magnetic Nanovectors for the Development of DNA Blood-Stage Malaria Vaccines.Counteracting antibiotic resistance: breaking barriers among antibacterial strategies.Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen.Vaccines: A review of immune-based interventions to prevent and treat disease.The promise of reverse vaccinology.Identification of proteins in Streptococcus pneumoniae by reverse vaccinology and genetic diversity of these proteins in clinical isolates.The study of H. pylori putative candidate factors for single- and multi-component vaccine development.Draft Genome Sequence of Neisseria gonorrhoeae Strain NG_869 with Penicillin, Tetracycline and Ciprofloxacin Resistance Determinants Isolated from Malaysia.Progress in vaccine development.Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBATowards developing a vaccine for rheumatic heart disease.The use of databases, data mining and immunoinformatics in vaccinology: where are we?Successful completion of a semi-automated enzyme-free cloning method.A reverse vaccinology approach to the identification and characterization of Ctenocephalides felis candidate protective antigens for the control of cat flea infestations.Identification of Streptococcus mitis321A vaccine antigens based on reverse vaccinology.
P2860
Q27680499-FD08A055-B9CF-4A7D-B55C-974E471D6BDAQ28074461-23418DE8-0881-4813-95F2-F281246D61ABQ28074750-1FF017DF-B1D4-4441-8022-E047A191276CQ28083737-2134248A-BF4C-4689-B3BF-835E99356D95Q30061569-4F9370E2-77F1-4A6F-9574-65AC82A74FC8Q34540352-2D59ACA7-BC73-42E7-A560-48984321D3CDQ35783015-27E857BE-F42E-4A3B-A865-F9AF1D0CE02CQ36616414-04B07C43-402D-40B7-9C3C-5C796FB094ECQ37076884-19951244-C657-4096-B9F8-A16AB173B69DQ37291569-804D2DDB-3A3C-4DD9-AAD6-CF4A57A58CF5Q37631622-6F858347-C731-44E0-8098-432FE8B3095FQ37676195-8992CF66-AE1F-404D-AC24-ED8BF92901A0Q38216443-FF35EBC3-AB0D-4918-B031-91C711E26521Q38363907-2B267EEE-F062-47B4-9E15-05AE5BC0E6EFQ38364468-FC980D10-10A9-4F5D-8C9E-FE1BAAE6E72DQ38367088-BA752679-ABC2-475A-B1FA-21D707874203Q39089994-2DBA3EF8-DEA6-4EB4-83C0-D39069FEC922Q39350897-DB4F98D3-982A-4252-985F-10738D55C5E4Q40560198-896F63EA-68B9-4C5B-8623-A45DF97B8E57Q41510529-C0203035-0040-4785-94DF-DCF25502789DQ41912569-1A13C2BA-1266-4991-B717-739E5F861987Q41928281-0DD90B65-E980-4412-BE2A-BA30C51D477CQ47262746-E017C6C9-B8E3-4180-B23D-6ABD2B77F9A9Q48119949-39B5C2C9-77D3-4EBC-B7E5-0A97715D3C48Q49955681-BE852E1E-E458-4A99-97A8-03FAA2DBC662Q55313789-5ADD6EBE-1CF8-4855-B49E-BF32484953E7
P2860
Vaccines, reverse vaccinology, and bacterial pathogenesis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Vaccines, reverse vaccinology, and bacterial pathogenesis.
@en
Vaccines, reverse vaccinology, and bacterial pathogenesis.
@nl
type
label
Vaccines, reverse vaccinology, and bacterial pathogenesis.
@en
Vaccines, reverse vaccinology, and bacterial pathogenesis.
@nl
prefLabel
Vaccines, reverse vaccinology, and bacterial pathogenesis.
@en
Vaccines, reverse vaccinology, and bacterial pathogenesis.
@nl
P2860
P1476
Vaccines, reverse vaccinology, and bacterial pathogenesis.
@en
P2093
Isabel Delany
Kate L Seib
P2860
P304
P356
10.1101/CSHPERSPECT.A012476
P577
2013-05-01T00:00:00Z